Khan Najat Insider Trades

Insider Trading History

Track insider trading activity for Khan Najat. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
CEO And President
Holding Value $8.36M 2,199,384 shares
Last Trade
May 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$191k 62,701 shares
$3.04
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
CEO And President
Holding Value $8.6M 2,262,085 shares
Last Trade
Mar 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$94.8k 28,298 shares
$3.35
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
CEO And President
Holding Value $8.7M 2,290,383 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$49.8k 14,280 shares
$3.49
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
CEO And President
Holding Value $8.76M 2,304,663 shares
Last Trade
Feb 06, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.2k 10,364 shares
$3.98
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
CEO And President
Holding Value $8.8M 2,315,027 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.78M 1,703,892 shares
$3.98
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.32M 611,135 shares
Last Trade
Dec 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$549k 124,403 shares
$4.41
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.8M 735,538 shares
Last Trade
Nov 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$72.8k 17,584 shares
$4.14
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.86M 753,122 shares
Last Trade
Nov 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 254,776 shares
$4.96
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.54M 668,197 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$202k 36,599 shares
$5.52
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.68M 704,796 shares
Last Trade
Aug 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.4k 3,789 shares
$5.64
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.69M 708,585 shares
Last Trade
May 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.1k 3,796 shares
$4.25
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.71M 712,381 shares
Last Trade
Feb 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20k 2,753 shares
$7.25
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $2.72M 715,134 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.05M 420,226 shares
$7.25
$3.80
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Chief R&d Commercial Officer
Holding Value $3.78M 993,944 shares
Last Trade
Aug 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.3M 993,944 shares
$7.34
$3.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up